Alterome Therapeutics Funding & Investors
Alterome Therapeutics is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers.
alterome.comTotal Amount Raised: $231,000,000
Alterome Therapeutics Funding Rounds
Series B
$132,000,000
Series B Investors
Goldman SachsOrbiMed AdvisorsCanaanNextech InvestBlue Owl CapitalVida VenturesInvusDigitalis VenturesColt VenturesBoxer CapitalDriehaus Capital ManagementSeries A
$64,000,000
Series A Investors
OrbiMed AdvisorsVida VenturesNextech InvestBoxer CapitalSeries A
$35,000,000
Series A Investors
Colt VenturesOrbiMed AdvisorsBoxer CapitalNextech InvestVida Ventures
Funding info provided by Diffbot.